Sai Parenterals subsidiary wins AUD 202M OTC supply deal in Australia

Order Above 5pct RevenueExport Order Hard CurrencyBusiness Updates View source PDF Explain this filing

SAIPARENT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.1%Reaction day

₹617.95

prior close

₹676.15

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.9%+0.2% vs market

Pharmaceuticals peers, median of 164sector+0.0%+1.0% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-4.2

10m

-4.5

15m

-6.0

30m

-5.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.1+0.9+0.2+0.0+1.0

Next day

+0.4+0.5-0.1+0.5-0.0

-1.3+0.7-2.0+0.0-1.3

-3.2+0.0-3.3-0.3-2.9

-4.4-2.0-2.4-1.2-3.2

-3.9-0.1-3.7-0.7-3.2

-5.0+1.4-6.4+0.4-5.4

15d

-13.1-1.4-11.7-1.4-11.7

-10.7+1.3-12.0-0.3-10.4

-16.4+3.8-20.1+1.1-17.4

-19.9+2.9-22.8+0.5-20.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Sai Parenterals' subsidiary Noumed Pharmaceuticals Pty Ltd has signed an exclusive OTC medicines supply agreement with Australia's leading pharmacy network. The contract is valued at AUD 202 million (around INR 1,300 crores) for 7.5 years, with an option to extend by 3 years. Effective from 1 July 2026. No promoter or related party interest is involved in the deal.

Likely market impact

Major multi-year export contract worth about INR 1,300 crores strengthens revenue visibility and international presence.